According to Emergen Research, the global GERD drugs and devices market size was USD 5.21 billion in 2020 and is expected to reach USD 6.28 billion in 2028 and register a revenue CAGR of 2.3% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “GERD Drugs and Devices Market, By Route of Administration (Oral, Parenteral), By Drug Type (H2 Receptor Antagonist, Proton Pump Inhibitors, Antacids), By Device Type (LINX Management System, Stretta Therapy, Bravo Reflux Testing System, MUSE – Medigus Ultrasonic Surgical Endostapler, Digitrapper Reflux Testing System, Others), and By Region, Forecast to 2028”
According to Emergen Research, the global GERD drugs and devices market size was USD 5.21 billion in 2020 and is expected to reach USD 6.28 billion in 2028 and register a revenue CAGR of 2.3% during the forecast period, 2021-2028.
Market Dynamics:
Key factors contributing to the revenue growth of the global GERD drugs and devices market are increasing geriatric population worldwide, rising prevalence of gastrointestinal diseases such as GERD (gastroesophageal reflux disease), changing lifestyles leading to increasing stress levels and excessive intake of alcohol, aerated drinks, and fast food, especially among the younger generation, and rising trend of self-medication and growing demand for generic and over-the-counter drugs for gastrointestinal disorders. Other major factors boosting revenue growth of the global GERD drugs and devices market are growing awareness of gastrointestinal diseases, rising need for early diagnosis and treatment, increasing volumes of GERD surgical procedures, and increasing investments in research & development of new and advanced GERD drugs and therapeutics. Also called acid reflux, GERD is a chronic digestive disorder characterized by irritation in the lining of the food pipe caused by inflow of bile (stomach acid). The disease is generally treated with prescription drugs including Famotidine (Pepcid), Nizatidine, and antacids such as Tums, Mylanta, and Rolaids. Frequent heartburn is one of the most common symptoms of the disease.
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/383
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Antacids Drug Type Segment Accounted for Largest Revenue Share in 2020:
Based on drug type, the global GERD drugs and devices market is segmented into H2 receptor antagonist, proton pump inhibitors, antacids. The antacids segment dominated other segments in terms of largest revenue share in the global market in 2020. Major factors boosting revenue growth of this segment are rise in geriatric population, increasing prevalence of gastroesophageal reflux disease, and growing demand for over-the-counter and generic medications for gastrointestinal disorders. Antacids are medications that help in neutralizing the stomach acid and thus relieving acid indigestion, sour stomach, heartburn, and upset stomach. Commonly used antacids include Gelusil, Maalox, Gaviscon, Mylanta, Pepto-Bismol, and Rolaids.
MUSE Device Type Segment to Account for Fastest Revenue CAGR:
Based on device type, the global GERD drugs and devices market is segmented into LINX management system, Stretta therapy, Bravo reflux testing system, MUSE (Medigus Ultrasonic Surgical Endostapler), Digitrapper reflux testing system, and others. The MUSE (Medigus Ultrasonic Surgical Endostapler) is expected to register the fastest revenue CAGR the global market over the forecast period. MUSE is an extensive endoscopic device for Transoral Fundoplication – the most common surgical procedure for the treatment of GERD – and is one of the most patient-friendly options.
Asia Pacific Market to Account for Fastest Revenue Growth Rate:
Among the regional markets, the Asia Pacific GERD drugs and devices market is projected to register the fastest revenue CAGR in the global market over the forecast period. Major factors prompting revenue growth of the Asia Pacific market are increasing prevalence of gastrointestinal diseases including GERD, rising volumes of diagnostic and surgical procedures for treatment of GERD, increasing demand for over-the-counter and generic medications, and growing preference for minimally invasive surgeries.
Make Payment [Buy your Exclusive copy]@ https://www.emergenresearch.com/select-license/383
Major Companies in the Global GERD Drugs and Devices Market Include:
- Johnson & Johnson
- AstraZeneca PLC
- Takeda Pharmaceutical Company Limited
- Pfizer Inc.
- Novartis AG
- GlaxoSmithKline Plc
- Merck & CO., Inc.
- Boston Scientific Corporation
- Eisai Co., Ltd.
- Ironwood Pharmaceuticals, Inc.
- Addex Therapeutic
- Takeda Pharmaceutical Company Limited
- Rottapharm (Meda AB)
- The Procter & Gamble Company
- Torax Medical Inc.
- Mederi Therapeutics
- Aros Pharma
- C. R. Bard, Inc.
- EndoGastric Solutions
- Medigus Ltd.
For the purpose of this report, Emergen Research has segmented the global GERD drugs and devices market based on route of administration, drug type, device type, and region:
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Oral
- Parenteral
Drug Type Outlook (Revenue, USD Billion; 2018-2028)
- H2 Receptor Antagonist
- Proton Pump Inhibitors (PPIs)
- Antacids
Device Type Outlook (Revenue, USD Billion; 2018-2028)
- MUSE (Medigus Ultrasonic Surgical Endostapler)
- LINX Management System
- Stretta Therapy
- Bravo Reflux Testing System
- Digitrapper Reflux Testing System
- Others
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/gerd-drugs-and-devices-market
By Region (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore our reports from Healthcare Catogory:
Single Use/Disposable Endoscopy Market By Product (Endoscope, Visualization Systems, Endoscopic Ultrasound, Insufflator), By Application (Bronchoscopy, Urologic Endoscopy, Arthroscopy, GI endoscopy, ENT Endoscopy, Others), By End-use (Hospitals, Healthcare Centers, Clinics), and By Region Forecast to 2028
Oncolytic Virus Therapies Market Size, Share, Trends, By Virus Type (Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses), By Application (Solid Tumors, Melanoma), By End-use (Hospitals, Specialty Clinics, Cancer Research Institute), and By Region, Forecast to 2028.
Hybrid Operating Room Market Size, Share, Trends, By Component (Surgical Instruments, Audiovisual Display Systems and Tools, Intraoperative Diagnostic Imaging Systems, Operating Room Fixtures), By Application, By End-use, and By Region and Country Forecast to 2028
Nanorobotics Market Size, Share, Trends, By Type (Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based), By Application (Nanomedicine, Biomedical, Mechanical, Others), and By Region Forecast to 2028
Nanotechnology Companies to Watch Out for in the Near Future
Top 10 Leading Facemask Manufacturing Companies in the World
Microfluidics: Miniaturizing Conventionally Sized Systems to Develop High-Precision Approaches
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-gerd-drugs-and-devices-market